Combining mathematical modeling, <i>in vitro</i> data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL.
第一作者:
Javier,Sanchez
第一单位:
Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland.;Department of Pharmacy, Uppsala University, Uppsala, Sweden.
作者:
DOI
10.3389/fphar.2024.1472662
PMID
39444607
发布时间
2024-10-25
- 浏览0
Frontiers in pharmacology
1472662页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



